Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your Favorites.
This session is in your Favorites. Click again to remove it.
Presentation Icons
ACG Award Winner
ACG Newsworthy Abstract
Registration Required
No CME
On-Demand Video
Livestream
Favorite
Email
Himaben Gohil, DO, MSc (she/her/hers)
University at Buffalo
Poster(s):
P1029 - Semaglutide and Tirzepatide Have the Most Clinical Benefit Compared to Most Weight Loss Medications in Inflammatory Bowel Disease
Sunday, October 26, 2025
3:30 PM - 7:00 PM
MT
P1030 - Evaluating the Key Risk Factors for Crohn’s Disease Flares in a Marginalized Population
Sunday, October 26, 2025
3:30 PM - 7:00 PM
MT
P1031 - Glucagon-Like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease: A Comparison of Agent-Specific Outcomes in Type 2 Diabetes and Obese Inflammatory Bowel Disease Populations
Sunday, October 26, 2025
3:30 PM - 7:00 PM
MT
P1931 - Conservative Management of Pneumatosis Intestinalis and Pneumoperitoneum in Patients With Autoimmune Conditions May Be Associated With Improved Clinical Outcomes
Sunday, October 26, 2025
3:30 PM - 7:00 PM
MT
Email Himaben
